EPHEDRINUM HYDROCHLORICUM
-
| StockNo |
Product description |
Status |
| EB0280-443-07 |
EPHEDRINUM
HYDROCHLORICUM TABL 50 MG X 10 |
 |
| EB0280-443-16 |
EPHEDRINUM
HYDROCHLORICUM AMPOULE 50 MG/1 ML (5%) |
 |
| EB0280-443-17 |
EPHEDRINUM
HYDROCHLORICUM OINTMENT 20 G |
 |
-
- COMPOSITION:
Ephedrine hydrochloride -
- 50 mg/l ml in one ampoule
50 mg in one tablet
3 % ointment
ACTION:
Ephedrine is an alkaloid obtained from the stems of the plants
of the family of Ephedraceae and is more active than the
preparation ephetonin produced synthetically. It belongs to the
group of sympathicomimetics, but its effect is weaker and more
prolonged than that of adrenaline. It inhibits the activity of
monoaminooxidase, stimulates alpha- and beta-adrenoreceptors. It
causes constriction of the peripheral vessels, accelerates the
heart rhythm, increases arterial pressure, dilates the bronchi,
inhibits intestinal peristalsis and dilates thew pupils. It
increases the metabolism by raising inessentially the blood
sugar level after therapeutic doses. In therapeutic doses it
exercises a weak stimulating effect on CNS (psychic and motor
restlessness, insomnia) and increases also the excitability of
the respiratory center. It possesses a "waking" action
in cases of intoxication with narcotics and hypnotics. The
suppression of the appetite is due to its central action. It
accumulates in more acid liquids (including the intracellular
liquid). Melanine concentrated in some pigment structures can
bind itself specifically with ephedrine.
PHARMACOKINETICS:
Owing to its greater stability, ephedrine is effective after oral
administration and is appropriate for prolonged treatment, it is
well absorbed in the gastrointestinal tract and is excreted with the
urine mainly unchanged. Its half-life is from 3 to 6 hours.
INDICATIONS:
Allergic disease: for prophylaxis and treatment of fits of bronchial
asthma combined with antispastic (novphylline, papaverine) and
sedative drugs; for treatment of hay fever, urticaria and allergic
rhinitis. It is applied in whooping-cough, chronic bronchitis and
lung emphysema.
For increase of BP in cases of: traumatic shock, operations,
hemorrhages; in case of decreased AP accompanying infectious
diseases; rarely in hypotension but only in people with satisfactory
functional state of the heart. Owing to its prolonged action,
ephedrine may be used for prophylaxis of vascular collapse (in
spinal anesthesia).
As a drug stimulating the respiratory center - in intoxications with
narcotics and hypnotics (morphine, barbiturates). Its central
stimulating action is used for treatment of narcolepsy and enuresis
nocturna.
Local application - in vasomotor rhinitis and acute sinusitis. |
CONTRAINDICATIONS:
Hypertension, atherosclerosis, severe organic heart diseases,
stenocardia, insomnia.
SIDE EFFECTS:
Sometimes 15-30 minutes after oral administration of the
preparation, a slight tremor and palpitation may be observed, but
they are short-lived. After overdosage - nausea, vomiting, loss of
appetite, nervous excitement, insomnia, tachycardia, circulation
disturbances, dizziness, disury (sometimes even when applied in
therapeutic doses), profuse perspiration, eruptions.
DRUG INTERACTIONS:
Combined therapy of ephedrine with reserpine and MAO-inhibitors may
cause a sharp decrease of blood pressure, the combination of
ephedrine with inderal decreases its broncholytic effect. Ephedrine
is an antagonist of the non-steroid analgesics and of the drugs
suppressing CNS.
PRECAUTIONS:
In order to avoid sleep disturbances, the preparation should not be
taken in the evening or before going to bed.
DOSAGE AND ADMINISTARTION:
Orally: adults - 0.002-0.02 g depending on age and body weight. The
treatment course lasts 10-15 days, with 3-day pauses every 3-4 days.
Subcutaneously or intramuscularly - 0.4-0.8 g of the injection
solution.
Intravenously the preparation is applied very slowly at a dose of
0.4 to 1 ml of a 55 solution or in the form of a dropwise infusion
at a dose of 0.06-0.08 g in 250-500 ml sodium chloride or 5 %
glucose solution.
Locally (per nasi) - 2-3 times from the ointment.
MEDICINAL FORM AND PACKAGE:
Ampoules of 50 mg/l ml (5%) in packs of 10, 50 and 100.
Tablets of 50 mg in packs of 10.
Ointment - in tubes of 20 g.
STORAGE:
At moderate temperature (15-30° C).
EXPIRY:
Ampoules and tablets - 5 (five) years.
Ointment - 2 (two) years.
|